» Articles » PMID: 1877673

Ischemic Contracture Begins when Anaerobic Glycolysis Stops: a 31P-NMR Study of Isolated Rat Hearts

Overview
Journal Am J Physiol
Specialty Physiology
Date 1991 Aug 1
PMID 1877673
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The relationships among myocardial ATP, intracellular pH, and ischemic contracture in Langendorff-perfused rat hearts were investigated by 31P nuclear magnetic resonance spectroscopy during total global normothermic ischemia while the left ventricular pressure was recorded continuously via an intraventricular balloon. Glucose-perfused hearts (n = 63) were divided into five groups based on the time of onset of contracture (TOC), and three other groups of hearts were treated to vary the ischemic glycogen availability. ATP levels, which showed no evidence of accelerated ATP depletion during contracture, were significant and variable at TOC. Intracellular pH initially declined and then leveled off at TOC, with lower final pH in hearts with later TOC. We conclude that contracture began when anaerobic glycolysis (and thus glycolytic ATP synthesis) stopped. These results, though consistent with the concept that ischemic contracture in normal hearts results from rigor bond formation due to low ATP levels at the myofibrils, suggest that TOC is more closely related to glycolytic ATP production than to total cellular ATP content, thus providing evidence of some degree of subcellular compartmentation or metabolite channeling. In glycolytically inhibited hearts, the quite early contracture may have a Ca2+ component.

Citing Articles

Effectiveness of advanced cardiovascular life support in hyperkalemic cardiac arrest: A randomized experimental study in pigs.

Mamadjonov N, Heo W, Jeung K, Jung Y, Lee H, Ryu S Heliyon. 2025; 11(2):e41743.

PMID: 39897916 PMC: 11787472. DOI: 10.1016/j.heliyon.2025.e41743.


Insulin and glycolysis dependency of cardioprotection by nicotinamide riboside.

Xiao Y, Wang Q, Zhang H, Nederlof R, Bakker D, Siadari B Basic Res Cardiol. 2024; 119(3):403-418.

PMID: 38528175 PMC: 11142987. DOI: 10.1007/s00395-024-01042-4.


Cardiometabolism as an Interlocking Puzzle between the Healthy and Diseased Heart: New Frontiers in Therapeutic Applications.

Pasqua T, Rocca C, Giglio A, Angelone T J Clin Med. 2021; 10(4).

PMID: 33673114 PMC: 7918460. DOI: 10.3390/jcm10040721.


Cardiac metabolism as a driver and therapeutic target of myocardial infarction.

Zuurbier C, Bertrand L, Beauloye C, Andreadou I, Ruiz-Meana M, Jespersen N J Cell Mol Med. 2020; 24(11):5937-5954.

PMID: 32384583 PMC: 7294140. DOI: 10.1111/jcmm.15180.


Effect of pralidoxime on coronary perfusion pressure during cardiopulmonary resuscitation in a pig model.

Jung Y, Ryu D, Jeung K, Na J, Lee D, Lee B Clin Exp Emerg Med. 2019; 6(3):204-211.

PMID: 31036784 PMC: 6774006. DOI: 10.15441/ceem.18.036.